Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Closed Date12/2013

General Information

Offices

Headquarters
300 Putnam Avenue
Cambridge, MA, 02139
USA

People

Board Member

Funding

Tags

Elixir Pharmaceuticals Closed down December, 2013

Elixir Pharmaceuticals

Elixir Pharmaceuticals is a pharmaceutical company focused on the discovery, development and commercialization of novel pharmaceuticals for the treatment of metabolic diseases such as diabetes and obesity. The Company’s scientific founders identified that interactions between specific genes and enzymes can slow the aging process, and they are developing compounds that stimulate these interactions and will be used to treat a range of diseases of aging, including metabolic disease.

Recent Milestones

Videos

Screenshots

Elixir Pharmaceuticals screenshot
Above: elixir0609
Uploaded: 6/17/09

Sources

  1. Elixir raises $46M for fountain of youth (venturebeat.com) [edit]
  2. Elixir Pharmaceuticals, Inc.: Series D $12M (onbiovc.com) [edit]
Edit This Page
Last Edited 2/2/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy